16.81
0.03 (0.18%)
| Previous Close | 16.78 |
| Open | 16.89 |
| Volume | 327,201 |
| Avg. Volume (3M) | 1,055,696 |
| Market Cap | 1,013,424,512 |
| Price / Earnings (Forward) | 41.32 |
| Price / Sales | 2.17 |
| Price / Book | 3.11 |
| 52 Weeks Range | |
| Earnings Date | 8 Dec 2025 |
| Profit Margin | -9.83% |
| Operating Margin (TTM) | -46.68% |
| Diluted EPS (TTM) | -0.740 |
| Quarterly Revenue Growth (YOY) | 45.70% |
| Total Debt/Equity (MRQ) | 2.60% |
| Current Ratio (MRQ) | 1.95 |
| Operating Cash Flow (TTM) | 47.95 M |
| Levered Free Cash Flow (TTM) | 35.26 M |
| Return on Assets (TTM) | -5.98% |
| Return on Equity (TTM) | -15.97% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Health Information Services (US) | Bearish | Mixed |
| Health Information Services (Global) | Bearish | Mixed | |
| Stock | Phreesia, Inc. | Bearish | Bullish |
AIStockmoo Score
| Analyst Consensus | 4.0 |
| Insider Activity | NA |
| Price Volatility | 3.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -2.5 |
| Average | 1.13 |
|
Phreesia Inc is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations by activating patients in their care to optimize patient health outcomes. Through its SaaS-based technology platform, it offers healthcare services clients a robust suite of integrated solutions that manage patient access, registration, payments, and clinical support. The Phreesia Platform encompasses a comprehensive range of technologies and services, including, initial patient contact, registration, automated answering services, appointment scheduling, payments, and post-appointment patient surveys. |
|
| Sector | Healthcare |
| Industry | Health Information Services |
| Investment Style | Small Core |
| % Held by Insiders | 4.32% |
| % Held by Institutions | 95.90% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Granahan Investment Management, Llc | 30 Sep 2025 | 1,380,626 |
| Deerfield Management Company, L.P. | 30 Sep 2025 | 1,116,752 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 35.00 (Needham, 108.21%) | Buy |
| 35.00 (DA Davidson, 108.21%) | Buy | |
| Median | 30.50 (81.44%) | |
| Low | 24.00 (Barclays, 42.77%) | Buy |
| Average | 30.20 (79.66%) | |
| Total | 10 Buy | |
| Avg. Price @ Call | 17.56 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Barclays | 16 Dec 2025 | 24.00 (42.77%) | Buy | 16.35 |
| 09 Dec 2025 | 26.00 (54.67%) | Buy | 15.43 | |
| Baird | 10 Dec 2025 | 25.00 (48.72%) | Buy | 15.78 |
| Mizuho | 10 Dec 2025 | 28.00 (66.57%) | Buy | 15.78 |
| Canaccord Genuity | 09 Dec 2025 | 33.00 (96.31%) | Buy | 15.43 |
| Citigroup | 09 Dec 2025 | 29.00 (72.52%) | Buy | 15.43 |
| JP Morgan | 09 Dec 2025 | 29.00 (72.52%) | Buy | 15.43 |
| Needham | 09 Dec 2025 | 35.00 (108.21%) | Buy | 15.43 |
| 08 Dec 2025 | 35.00 (108.21%) | Buy | 20.12 | |
| DA Davidson | 02 Dec 2025 | 35.00 (108.21%) | Buy | 20.15 |
| BMO Capital | 13 Nov 2025 | 32.00 (90.36%) | Buy | 22.53 |
| Keybanc | 08 Oct 2025 | 32.00 (90.36%) | Buy | 23.25 |
| Show more | ||||
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 18 Dec 2025 | Announcement | Phreesia Named to The Software Report’s “Top 50 Software Companies” for the Fourth Consecutive Year |
| 08 Dec 2025 | Announcement | Phreesia Announces Third Quarter Fiscal 2026 Results and Introduces Fiscal 2027 Outlook |
| 04 Dec 2025 | Announcement | Phreesia’s Megan Turco Named to MM+M 40 Under 40 |
| 19 Nov 2025 | Announcement | Phreesia Named to the 2025 Deloitte Technology Fast 500™ |
| 03 Nov 2025 | Announcement | Phreesia Sets Release Date for Fiscal Third Quarter 2026 Results |
| 08 Oct 2025 | Announcement | Phreesia Named to the 2025 Capterra Shortlists for Appointment Reminders and Appointment Scheduling |
| 30 Sep 2025 | Announcement | Phreesia Named to TIME’s 2025 List of the World’s Top HealthTech Companies |
| 5Y Average Dividend Yield | 0.00% |
| Ex Date | Announcement Date | Payment Date | Details |
|---|---|---|---|
| 29 May 2013 | 07 Feb 2013 | 17 Jun 2013 | 0.5625 Cash |
| 27 Feb 2013 | 06 Feb 2013 | 15 Mar 2013 | 0.5625 Cash |
| 28 Nov 2012 | - | 15 Dec 2012 | 0.5625 Cash |
| 29 Aug 2012 | - | 15 Sep 2012 | 0.5625 Cash |
| 30 May 2012 | - | 15 Jun 2012 | 0.5625 Cash |
| 28 Feb 2012 | - | 15 Mar 2012 | 0.5625 Cash |
| 30 Aug 2011 | - | 15 Sep 2011 | 0.5625 Cash |
| 27 May 2011 | - | 15 Jun 2011 | 0.5625 Cash |
| 25 Feb 2011 | - | 15 Mar 2011 | 0.5625 Cash |
| 29 Nov 2010 | - | 15 Dec 2010 | 0.5625 Cash |
| 30 Aug 2010 | - | 15 Sep 2010 | 0.5625 Cash |
| 27 May 2010 | - | 15 Jun 2010 | 0.5625 Cash |
| 25 Feb 2010 | - | 15 Mar 2010 | 0.5625 Cash |
| 27 Nov 2009 | - | 15 Dec 2009 | 0.5625 Cash |
| 28 Aug 2009 | - | 15 Sep 2009 | 0.5625 Cash |
| 28 May 2009 | - | 15 Jun 2009 | 0.5625 Cash |
| 25 Feb 2009 | - | 16 Mar 2009 | 0.5625 Cash |
| 26 Nov 2008 | - | 15 Dec 2008 | 0.5625 Cash |
| 27 Aug 2008 | - | 15 Sep 2008 | 0.46875 Cash |
| Show more | |||
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |